[EN] PYRAZOLO[1,5-D][1,2,4]TRIAZINES FOR ENHANCING COGNITION<br/>[FR] GROUPE PYRAZOLO[1,5-D][1,2,4]TRIAZINES DESTINE A AMELIORER LA COGNITION
申请人:MERCK SHARP & DOHME
公开号:WO2001038331A2
公开(公告)日:2001-05-31
The present invention provides compounds of formula (I), or a salt thereof: wherein R1 represents halogen; or C¿1-6?alkyl,C3-7cycloalkyl, C4-7cycloalkenyl, C6-8 bicycloalkyl, C6-10aryl, C3-7 heterocycloalkyl, heteroaryl or di(C1-6)alkylamino, any of which groups may be optionally substituted; L is O, S or NR?n¿ where Rn is H, C¿1-6?alkyl or C3-6cycloalkyl; W is: C1-6alkyl, C2-6alkenyl or C2-6alkynyl optionally substituted; X is NR?4R5¿; or X is a 5-membered or a 6-membered heteroaromatic ring the 5- or 6-membered heteroaromatic ring being optionally fused to a benzene or pyridine ring and the heteroaromatic ring being optionally substituted; Y is optionally branched C¿1-4?alkylene optionally substituted by an oxo group or Y is a group (CH2)jO wherein the oxygen atom is nearest the group X and j is 2, 3 or 4; and Z represents a 5-membered or a 6-membered heteroaromatic ring any of which rings may be optionally substituted; pharmaceutical compositions containing them, their use in methods of treatment, and the use of them for manufacturing treatments for enhancing cognition, particularly in Alzheimer's Disease, and corresponding methods of treatment; the compounds are ligands and inverse agonists for the GABA-A alpha 5 receptor subtype.